Our Impact

We Are Committed 

Advancing Heart Rhythm Health

Our Networks goals and commitments are to finding innovative solutions to reduce premature death and suffering caused by heart rhythm disturbances (arrhythmias).

10 / 20 / 30
Clinical Targets

10% reduction in sudden cardiac death
20% reduction in atrial fibrillation hospitalization and emergency department visits
30% reduction in syncope hospitalization and emergency department visits

5-7 Technologies
Strategic Business and Capacity Development Targets

CANet is currently supporting the advancement of 10 commercial opportunities across its Network of investigators and industry partners. Already, CANet has supported the filing of multiple patents, the development of new and improved medical devices and facilitated the start of multiple companies towards its goal of commercializing 5-7 technologies.

200 Highly Qualified Personnel (HQP)
30-40 Careers Launched in Public and Private Research

CANet is building the next generation of scientists with the skills needed to optimize knowledge creation and translation in a changing world.

We provide unique and innovative training programs focused on building new skills in an inter-sectoral environment as well as one where patients are active partners in the research enterprise.

Already, 12 CHAT Members have graduated into full-time careers in public and private research roles.

Arrhythmia Care Delivery
Improve Efficiency, Effectiveness, and Accessibility

CANet is facilitating access for all Canadians to early detection, effective prevention, efficient and timely treatment of arrhythmia and related conditions through a transformed, patient-driven care model.

$40 Million In Research Contributions
Industry, Government and Not-for-Profit Sectors

Our goal was to leverage the investment of the NCE program into an additional $40M dollar contribution from our partners. In just three years, CANet has achieved that goal bringing in $45.5M

During this time of innovative research and technological advancement, CANet continues to form several new exciting collaborative partnerships.

Dr. Anthony Tang
Scientific Director and CEO, Cardiac Arrhythmia Network of Canada (CANet)

Need More Info?

Interested in learning more about our impact?

Yes, please subscribe me to the CANet newsletter